RELMADA THERAPEUTICS, INC. Sale of Stock, Price Per Share
RELMADA THERAPEUTICS, INC. (RLMD) had Sale of Stock, Price Per Share of $17.00 per share as of 2021-12-08, per its 10-K filed 2023-03-23.
Discontinued › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2023-03-23
- 2021-12-08: Sale of Stock, Price Per Share $17.00.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2021-12-08 | $17.00 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |